Clinical trials
Recruiting Phase 2 Atrial Fibrillation trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acesion Pharma | 1 |
| Bayer | 1 |
| GCP-Service International West GmbH | 1 |
| Huashan Hospital | 1 |
| National Cheng-Kung University Hospital | 1 |
| Novartis Pharmaceuticals | 1 |
| OHSU Knight Cancer Institute | 1 |
| Regeneron Pharmaceuticals | 1 |
| The Cleveland Clinic | 1 |
| University of South Florida | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 12 |
| Arrhythmias, Cardiac | 1 |
| Atrial Flutter | 1 |
| Esophageal Neoplasms | 1 |
| Hemorrhage | 1 |
| Hypertension | 1 |
| Obesity | 1 |
| Stroke | 1 |
| Thrombosis | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.